SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
189 hedge funds and large institutions have $2.69B invested in Sage Therapeutics in 2017 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 71 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
2.79% more ownership
Funds ownership: 98.83% → 101.61% (+2.8%)
28% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 71
63% less call options, than puts
Call options by funds: $53.6M | Put options by funds: $145M
Holders
189
Holding in Top 10
7
Calls
$53.6M
Puts
$145M
Top Buyers
| 1 | +$201M | |
| 2 | +$95.6M | |
| 3 | +$55.1M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$23.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.6M |
Top Sellers
| 1 | -$35.2M | |
| 2 | -$20.6M | |
| 3 | -$19.2M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$17.2M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$16.3M |